Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04455035 · ClinicalTrials.gov registry record · NA

DynaCleft® Effects on Soft Tissues and on Quality of Life for Incomplete Unilateral Cleft Lip Infants

A NA study, sponsored by The University of Texas Health Science Center, Houston.

Terminated
Registry status
NA
Development phase
24
Enrollment target

NCT04455035 is a NA study that was terminated before completion, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 24 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04455035, a NA study, was terminated before completion, sponsored by The University of Texas Health Science Center, Houston.

TERMINATED
Registry status
NA
Development phase
24 participants
Enrollment target

Study Summary

The purpose of this study is to examine the effectiveness of the DynaCleft® system on soft tissues of infants with unilateral incomplete cleft lip and to assess influences on quality of life for infants who underwent DynaCleft® and that of their families.

Interventions

  • OTHER Comparator: Retrospective Group(Control)
  • DEVICE Prospective Group

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2020-09-21
Est. Completion 2021-04-06
Phase NA

What the Registry Record Tells You About NCT04455035

The ClinicalTrials.gov registry entry for NCT04455035 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Comparator: Retrospective Group(Control) is the first listed.

NCT04455035 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04455035 about?

NCT04455035 is a clinical study titled "DynaCleft® Effects on Soft Tissues and on Quality of Life for Incomplete Unilateral Cleft Lip Infants". The purpose of this study is to examine the effectiveness of the DynaCleft® system on soft tissues of infants with unilateral incomplete cleft lip and to assess influences on quality of life for infants who underwent DynaCleft® and that of their families.

What is the current status of trial NCT04455035?

This trial is currently terminated. It is a NA study. The enrollment target is 24 participants. The study started on 2020-09-21. Estimated completion is 2021-04-06.

What interventions are being tested in trial NCT04455035?

The interventions under investigation include: Comparator: Retrospective Group(Control) (OTHER), Prospective Group (DEVICE).

Who is sponsoring clinical trial NCT04455035?

This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.